Please assess the completion status of the following clinical trial:

Trial Title: Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* ages 18 and older~* complaint of nausea and/or vomiting reported at 3 or above on verbal numerical rating scale at the time of triage~Exclusion Criteria:~* allergy to isopropyl alcohol or ondansetron~* inability to breathe through nose (e.g., recent upper respiratory infection)~* intake of cefoperazone, disulfiram, or metronidazole within the last 24 hours~* mental status precluding informed consent including intoxication~* known QT-prolongation~* clinical suspicion for serotonin syndrome~* intravenous catheter in place prior to study start~* medications administered since patient arrival (e.g., in triage)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Inhaled ISO + oral ondansetron (Type: ACTIVE_COMPARATOR): Inhaled isopropyl alcohol pads as needed for nausea (up to q30 minutes) and drink oral elixir comprising ondansetron (4 mg).
- Inhaled ISO + oral placebo (Type: EXPERIMENTAL): Inhaled isopropyl alcohol pads as needed for nausea (up to q30 minutes) and drink oral placebo elixir.
- Inhaled placebo + oral ondansetron (Type: ACTIVE_COMPARATOR): Inhaled normal saline pads as needed for nausea (up to q30 minutes) and drink oral placebo elixir.

Based on this trial design, predict the completion outcome and termination type (if applicable).